Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-25 @ 2:42 AM
NCT ID:
NCT06582433
Brief Summary:
This research will be conducted in a prospective pre-test post-test measurement randomized controlled experimental design. The population of the study consists of women who have entered menopause and live in Karabük. The research sample size was calculated considering the literature information that in experimental studies each group should consist of at least 30 individuals, taking into account the power of the test with G\*Power 3.1 Program. It was calculated that at least 32 observations are needed in both the experimental and control groups to reach a power level of 90% at a significance level of 5% with an effect size of 0.75, and the sample size of the study was calculated as 64 women. The data of the study will be collected using the "Personal Information Form", "Psychological Well-being Scale", "Menopausal Symptoms Evaluation Scale" and "Menopause Attitude Evaluation Scale".
WORKFLOW
Pre-procedure:
* Women who meet the inclusion criteria for the study will be divided into experimental and control groups using simple randomization method.
* Before the procedure, women in both groups will fill out the PIF, PWBS, MSES, and MAES (1st Measurement).
During the procedure:
At this stage, Solution-Focused Counseling (SFC) will be used on women in the experimental group by the researcher. SFC sessions for patients will be held individually, once a week, with a total of 6 sessions that may have deviations of 2-3 days before or after the previous session. Each session is planned to last 60 minutes. Counseling for patients will be conducted in a comfortable environment. At this stage, women in the control group will be given information on typical menopausal symptoms.
Post-procedure:
One week after the completion of SFC sessions, the PIF, PWBS, MSES, and MAES will be filled out by the experimental and control groups (2nd Measurement).
Follow-up evaluation after 2 months:
Two months after the completion of SFC sessions, the PIF, PWBS, MSES, and MAES will be applied to the experimental and control groups (Follow-up Measurement) to determine whether the results of the applied SFC are continuing.After monitoring measurements are taken on the control group, counseling will be provided to women according to their needs (addressing issues, answering questions, informing them according to their needs).
Detailed Description:
The aim of this research is to examine the effectiveness of solution-focused counseling in managing menopausal symptoms and to investigate the impact of this approach on the attitudes and psychological well-being of women in the menopausal period.
H1: Solution-focused counseling affects the evaluation of menopausal symptoms in women in the menopausal period.
H2: Solution-focused counseling leads to changes in attitudes towards menopause in women in the menopausal period.
H3: Solution-focused counseling affects the level of psychological well-being of women in the menopausal period.
Study:
NCT06582433
Study Brief:
Protocol Section:
NCT06582433